BPL‑003 holds Breakthrough Therapy Designation and is supported by positive Phase 2b results in treatment-resistant depressionCash runway ...

Norwin residents got a fresh look at the future of Friday nights on Sunday, when new renderings for a rebuilt Norwin Knights ...

AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...

Carson City Manager Glen Martel is recommending supervisors authorize negotiations on the design, construction and eventual ...

"If a valid requisition is confirmed, the organisation will call a meeting within the required timeframe" says AusCycling ...

The operations of Gauzy SAS, Safety Tech, and Vision Systems continue during the observation period of the ongoing court-supervised reorganization proceedings ( redressement judiciaire) opened on ...

A new team to help Novato Unified School District with its education workforce housing plans has made its first public ...

Apollo.io reports C-suite executives need to understand agentic GTM as a strategic foundation, emphasizing data quality, ...

NervGen Pharma Corp. NVG-291 shows lasting gains in chronic spinal cord injury; Phase 3 and FDA fast paths ahead. Click for this NGEN update.

Aligned with FDA on dual-trial design Phase 3 program that aims to demonstrate robust efficacy and long-term safety and that allows for flexible dosingPhase 3 program initiation remains on track for ...

What makes a good school fit for your child? It helps to review how the state's broader landscape shapes private school ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that ...